Knowledge

PMM2 deficiency

Source đź“ť

37: 157:
Treatment with mannose powder 1 to 2 g / kg per day results in significant improvement in protein glycosylation after 1 year. Other treatments involve management of the symptoms that are apparent in each individual, including physical therapy to improve core strength and mobility, occupational
619:
Footitt EJ, Karimova A, Burch M, Yayeh T, Dupré T, Vuillaumier-Barrot S, Chantret I, Moore SE, Seta N, Grunewald S (December 2009). "Cardiomyopathy in the congenital disorders of glycosylation (CDG): a case of late presentation and literature review".
175:
Matthijs G, Schollen E, Pardon E, Veiga-Da-Cunha M, Jaeken J, Cassiman JJ, Van Schaftingen E (May 1997). "Mutations in PMM2, a phosphomannomutase gene on chromosome 16p13, in carbohydrate-deficient glycoprotein type I syndrome (Jaeken syndrome)".
575:
Marques-da-Silva D, Dos Reis Ferreira V, Monticelli M, Janeiro P, Videira PA, Witters P, Jaeken J, Cassiman D (March 2017). "Liver involvement in congenital disorders of glycosylation (CDG). A systematic review of the literature".
75:
or CDG. PMM2-CDG is the most common of a growing family of more than 130 extremely rare inherited metabolic disorders. Only about 800 children and adults have been reported worldwide.
295:
Al-Maawali AA, Miller E, Schulze A, Yoon G, Blaser SI (February 2014). "Subcutaneous fat pads on body MRI--an early sign of congenital disorder of glycosylation PMM2-CDG (CDG1a)".
30:
Carbohydrate-deficient Glycoprotein Syndrome (CDGS) Type Ia, Congenital Disorder of Glycosylation (CDG) Type Ia,Phosphomannomutase Deficiency,Jaeken Syndrome, PMM2-CDG , CDG1a
389:
Serrano NL, De Diego V, Cuadras D, Martinez Monseny AF, Velázquez-Fragua R, López L, Felipe A, Gutiérrez-Solana LG, Macaya A, Pérez-Dueñas B, Serrano M (September 2017).
440:
de Diego V, Martínez-Monseny AF, Muchart J, Cuadras D, Montero R, Artuch R, Pérez-Cerdá C, Pérez B, Pérez-Dueñas B, Poretti A, Serrano M (September 2017).
442:"Erratum to: Longitudinal volumetric and 2D assessment of cerebellar atrophy in a large cohort of children with phosphomannomutase deficiency (PMM2-CDG)" 883: 340:"Stroke-Like Episodes and Cerebellar Syndrome in Phosphomannomutase Deficiency (PMM2-CDG): Evidence for Hypoglycosylation-Driven Channelopathy" 878: 391:"A quantitative assessment of the evolution of cerebellar syndrome in children with phosphomannomutase-deficiency (PMM2-CDG)" 338:
Izquierdo-Serra M, MartĂ­nez-Monseny AF, LĂłpez L, Carrillo-GarcĂ­a J, Edo A, Ortigoza-Escobar JD, et al. (February 2018).
532:
Barone R, Fiumara A, Jaeken J (July 2014). "Congenital disorders of glycosylation with emphasis on cerebellar involvement".
72: 244: 219: 813:
Taday, Roman; GrĂĽneberg, Marianne; DuChesne, Ingrid; Reunert, Janine; Marquardt, Thorsten (2020-09-22).
111:- Impaired nerve impulse transmission to the legs. Patients do not respond well to reflex tests. 481:
Serrano M, de Diego V, Muchart J, Cuadras D, Felipe A, Macaya A, et al. (October 2015).
108: 90: 102: 8: 670:. In Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJ, Stephens K, Amemiya A (eds.). 145:
PMM2 deficiency is diagnosed through genetic sequencing. More than 115 mutations in the
849: 814: 722: 697: 645: 601: 557: 509: 482: 417: 390: 366: 339: 320: 201: 854: 836: 768: 727: 675: 637: 593: 549: 514: 463: 422: 371: 312: 193: 127: 84: 747:"Child Neurology: a case of PMM2-CDG (CDG 1a) presenting with unusual eye movements" 649: 605: 561: 324: 205: 844: 826: 758: 717: 709: 629: 585: 541: 504: 494: 453: 412: 402: 361: 351: 337: 304: 269: 185: 62: 574: 763: 746: 831: 815:"Dietary mannose supplementation in phosphomannomutase 2 deficiency (PMM2-CDG)" 789: 713: 667: 633: 589: 499: 458: 441: 407: 308: 872: 840: 96: 93:- Small cerebellum, which is the part of the brain that coordinates movement. 483:"Phosphomannomutase deficiency (PMM2-CDG): ataxia and cerebellar assessment" 858: 772: 731: 679: 641: 597: 553: 545: 518: 467: 426: 375: 316: 197: 356: 36: 114: 71:. It is an autosomal recessive disease that is the most common type of 439: 388: 189: 698:"Ophthalmic findings in an infant with phosphomannomutase deficiency" 133: 123: 118: 174: 276:. National Organization for Rare Disorders (NORD). 6 August 2015 158:
therapy for coordination, speech therapy for talking and eating.
812: 480: 294: 136:- Weak muscle tone, commonly known as floppy baby syndrome. 67: 618: 87:- Failure to gain weight and grow at the expected rate. 702:
Documenta Ophthalmologica. Advances in Ophthalmology
695: 674:. Seattle (WA): University of Washington, Seattle. 531: 691: 689: 870: 665: 696:Messenger WB, Yang P, Pennesi ME (April 2014). 686: 661: 659: 117:- Crossed eyes, mainly presented as infantile 245:"Congenital Disorders of Glycosylation (CDG)" 220:"Congenital Disorders of Glycosylation (CDG)" 149:gene have been found to cause this disease. 656: 344:International Journal of Molecular Sciences 744: 35: 848: 830: 762: 721: 508: 498: 457: 416: 406: 365: 355: 871: 784: 782: 622:Journal of Inherited Metabolic Disease 578:Journal of Inherited Metabolic Disease 446:Journal of Inherited Metabolic Disease 126:- Involuntary eye movements caused by 884:Congenital disorders of glycosylation 78: 73:congenital disorder of glycosylation 779: 249:Children's Hospital of Philadelphia 224:Children's Hospital of Philadelphia 13: 745:Coorg R, Lotze TE (October 2012). 14: 895: 819:Orphanet Journal of Rare Diseases 666:Sparks SE, Krasnewich DM (1993). 487:Orphanet Journal of Rare Diseases 395:Orphanet Journal of Rare Diseases 99:- Elevated liver function tests. 806: 738: 612: 568: 525: 879:Genetic diseases and disorders 474: 433: 382: 331: 288: 262: 237: 212: 168: 1: 161: 764:10.1212/WNL.0b013e31826e2617 152: 140: 7: 10: 900: 832:10.1186/s13023-020-01528-z 109:Peripheral neuropathy (PN) 714:10.1007/s10633-014-9427-0 634:10.1007/s10545-009-1262-1 590:10.1007/s10545-016-0012-4 500:10.1186/s13023-015-0358-y 459:10.1007/s10545-017-0056-0 408:10.1186/s13023-017-0707-0 309:10.1007/s00247-013-2782-2 105:- Fluid around the heart. 43: 34: 26: 21: 794:Genetics Home Reference 85:Failure to thrive (FTT) 65:caused by mutations in 546:10.1055/s-0034-1387197 534:Seminars in Neurology 91:Cerebellar hypoplasia 357:10.3390/ijms19020619 103:Pericardial effusion 668:"PMM2-CDG (CDG-Ia)" 628:(Suppl 1): S313-9. 297:Pediatric Radiology 79:Signs and symptoms 190:10.1038/ng0597-88 128:cerebellar ataxia 61:, is a very rare 48: 47: 16:Medical condition 891: 863: 862: 852: 834: 810: 804: 803: 801: 800: 786: 777: 776: 766: 742: 736: 735: 725: 693: 684: 683: 663: 654: 653: 616: 610: 609: 572: 566: 565: 529: 523: 522: 512: 502: 478: 472: 471: 461: 437: 431: 430: 420: 410: 386: 380: 379: 369: 359: 335: 329: 328: 292: 286: 285: 283: 281: 266: 260: 259: 257: 255: 241: 235: 234: 232: 230: 216: 210: 209: 172: 63:genetic disorder 39: 19: 18: 899: 898: 894: 893: 892: 890: 889: 888: 869: 868: 867: 866: 811: 807: 798: 796: 788: 787: 780: 743: 739: 694: 687: 664: 657: 617: 613: 573: 569: 530: 526: 479: 475: 438: 434: 387: 383: 336: 332: 293: 289: 279: 277: 268: 267: 263: 253: 251: 243: 242: 238: 228: 226: 218: 217: 213: 178:Nature Genetics 173: 169: 164: 155: 143: 81: 51:PMM2 deficiency 22:PMM2 deficiency 17: 12: 11: 5: 897: 887: 886: 881: 865: 864: 805: 778: 757:(15): e131-3. 737: 685: 655: 611: 584:(2): 195–207. 567: 524: 473: 452:(5): 753–754. 432: 381: 330: 287: 261: 236: 211: 166: 165: 163: 160: 154: 151: 142: 139: 138: 137: 131: 121: 112: 106: 100: 94: 88: 80: 77: 46: 45: 41: 40: 32: 31: 28: 24: 23: 15: 9: 6: 4: 3: 2: 896: 885: 882: 880: 877: 876: 874: 860: 856: 851: 846: 842: 838: 833: 828: 824: 820: 816: 809: 795: 791: 785: 783: 774: 770: 765: 760: 756: 752: 748: 741: 733: 729: 724: 719: 715: 711: 708:(2): 149–53. 707: 703: 699: 692: 690: 681: 677: 673: 669: 662: 660: 651: 647: 643: 639: 635: 631: 627: 623: 615: 607: 603: 599: 595: 591: 587: 583: 579: 571: 563: 559: 555: 551: 547: 543: 540:(3): 357–66. 539: 535: 528: 520: 516: 511: 506: 501: 496: 492: 488: 484: 477: 469: 465: 460: 455: 451: 447: 443: 436: 428: 424: 419: 414: 409: 404: 400: 396: 392: 385: 377: 373: 368: 363: 358: 353: 349: 345: 341: 334: 326: 322: 318: 314: 310: 306: 302: 298: 291: 275: 274:Rare Diseases 271: 265: 250: 246: 240: 225: 221: 215: 207: 203: 199: 195: 191: 187: 183: 179: 171: 167: 159: 150: 148: 135: 132: 129: 125: 122: 120: 116: 113: 110: 107: 104: 101: 98: 97:Liver disease 95: 92: 89: 86: 83: 82: 76: 74: 70: 69: 64: 60: 57:, previously 56: 52: 42: 38: 33: 29: 25: 20: 822: 818: 808: 797:. Retrieved 793: 754: 750: 740: 705: 701: 672:GeneReviews® 671: 625: 621: 614: 581: 577: 570: 537: 533: 527: 490: 486: 476: 449: 445: 435: 398: 394: 384: 347: 343: 333: 303:(2): 222–5. 300: 296: 290: 278:. Retrieved 273: 264: 252:. Retrieved 248: 239: 227:. Retrieved 223: 214: 184:(1): 88–92. 181: 177: 170: 156: 146: 144: 66: 58: 54: 50: 49: 44:PMM2 protein 790:"PMM2 gene" 27:Other names 873:Categories 825:(1): 258. 799:2018-03-12 401:(1): 155. 350:(2): 619. 280:1 December 270:"PMM2-CDG" 254:1 December 229:1 December 162:References 115:Strabismus 841:1750-1172 751:Neurology 153:Treatment 141:Diagnosis 134:Hypotonia 124:Nystagmus 119:esotropia 859:32962735 773:23045520 732:24493206 680:20301289 650:40744073 642:19757145 606:28342989 598:28108845 562:23836020 554:25192513 519:26502900 468:28600669 427:28915903 376:29470411 325:36990231 317:24037084 206:22959423 55:PMM2-CDG 850:7510076 723:3990245 510:4623922 493:: 138. 418:5602850 367:5855841 198:9140401 857:  847:  839:  771:  730:  720:  678:  648:  640:  604:  596:  560:  552:  517:  507:  466:  425:  415:  374:  364:  323:  315:  204:  196:  59:CDG-Ia 646:S2CID 602:S2CID 558:S2CID 321:S2CID 202:S2CID 855:PMID 837:ISSN 769:PMID 728:PMID 676:PMID 638:PMID 594:PMID 550:PMID 515:PMID 464:PMID 423:PMID 372:PMID 313:PMID 282:2023 256:2023 231:2023 194:PMID 147:PMM2 68:PMM2 845:PMC 827:doi 759:doi 718:PMC 710:doi 706:128 630:doi 586:doi 542:doi 505:PMC 495:doi 454:doi 413:PMC 403:doi 362:PMC 352:doi 305:doi 186:doi 53:or 875:: 853:. 843:. 835:. 823:15 821:. 817:. 792:. 781:^ 767:. 755:79 753:. 749:. 726:. 716:. 704:. 700:. 688:^ 658:^ 644:. 636:. 626:32 624:. 600:. 592:. 582:40 580:. 556:. 548:. 538:34 536:. 513:. 503:. 491:10 489:. 485:. 462:. 450:40 448:. 444:. 421:. 411:. 399:12 397:. 393:. 370:. 360:. 348:19 346:. 342:. 319:. 311:. 301:44 299:. 272:. 247:. 222:. 200:. 192:. 182:16 180:. 861:. 829:: 802:. 775:. 761:: 734:. 712:: 682:. 652:. 632:: 608:. 588:: 564:. 544:: 521:. 497:: 470:. 456:: 429:. 405:: 378:. 354:: 327:. 307:: 284:. 258:. 233:. 208:. 188:: 130:.

Index


genetic disorder
PMM2
congenital disorder of glycosylation
Failure to thrive (FTT)
Cerebellar hypoplasia
Liver disease
Pericardial effusion
Peripheral neuropathy (PN)
Strabismus
esotropia
Nystagmus
cerebellar ataxia
Hypotonia
doi
10.1038/ng0597-88
PMID
9140401
S2CID
22959423
"Congenital Disorders of Glycosylation (CDG)"
"Congenital Disorders of Glycosylation (CDG)"
"PMM2-CDG"
doi
10.1007/s00247-013-2782-2
PMID
24037084
S2CID
36990231
"Stroke-Like Episodes and Cerebellar Syndrome in Phosphomannomutase Deficiency (PMM2-CDG): Evidence for Hypoglycosylation-Driven Channelopathy"

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.

↑